Tritonpoint Wealth, LLC Arcturus Therapeutics Holdings Inc. Transaction History
Tritonpoint Wealth, LLC
- $957 Billion
- Q1 2024
A detailed history of Tritonpoint Wealth, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Tritonpoint Wealth, LLC holds 28,072 shares of ARCT stock, worth $675,693. This represents 0.09% of its overall portfolio holdings.
Number of Shares
28,072
Previous 28,072
-0.0%
Holding current value
$675,693
Previous $885 Million
-0.0%
% of portfolio
0.09%
Previous 0.09%
Shares
1 transactions
Others Institutions Holding ARCT
# of Institutions
193Shares Held
27.2MCall Options Held
294KPut Options Held
318K-
Federated Hermes, Inc. Pittsburgh, PA4.7MShares$113 Million0.37% of portfolio
-
Black Rock Inc. New York, NY2.74MShares$66 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl1.96MShares$47.3 Million0.44% of portfolio
-
State Street Corp Boston, MA1.96MShares$47.2 Million0.0% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.1.56MShares$37.6 Million0.03% of portfolio
About Arcturus Therapeutics Holdings Inc.
- Ticker ARCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,576,400
- Market Cap $640M
- Description
- Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...